



Abstract—Diabetes is a medical condition that can lead to 
various diseases such as stroke, heart disease, blindness and obesity. 
In clinical practice, the concern of the diabetic patients towards the 
blood glucose examination is rather alarming as some of the 
individual describing it as something painful with pinprick and pinch. 
As for some patient with high level of glucose level, pricking the 
fingers multiple times a day with the conventional glucose meter for 
close monitoring can be tiresome, time consuming and painful. With 
these concerns, several non-invasive techniques were used by 
researchers in measuring the glucose level in blood, including 
ultrasonic sensor implementation, multisensory systems, absorbance 
of transmittance, bio-impedance, voltage intensity, and 
thermography. This paper is discussing the application of the near-
infrared (NIR) spectroscopy as a non-invasive method in measuring 
the glucose level and the implementation of the linear system 
identification model in predicting the output data for the NIR 
measurement. In this study, the wavelengths considered are at the 
1450 nm and 1950 nm. Both of these wavelengths showed the most 
reliable information on the glucose presence in blood. Then, the 
linear Autoregressive Moving Average Exogenous model (ARMAX) 
model with both un-regularized and regularized methods was 
implemented in predicting the output result for the NIR measurement 
in order to investigate the practicality of the linear system in this 
study. However, the result showed only 50.11% accuracy obtained 
from the system which is far from the satisfying results that should be 
obtained.  
 
Keywords—Diabetes, glucose level, linear, near-infrared (NIR), 
non-invasive, prediction system. 
I. INTRODUCTION 
NOWN as the central carbohydrate, glucose derived from 
the Greek word “glykys”, meaning “sweet”, with two 
optical isomers, D-glucose and L-glucose [1]. For human 
body, glucose is very important, and frequent blood-glucose 
sensing is important for diabetic patients to maintain their 
glucose level in the normal clinical range (3.5–6.1 mmol/L) 
[2]. However, the diabetes disease can occur with the poor 
management of dietary of individual. About 347 million 
people suffered from diabetes in 2004, and an estimated 3.4 
million patients died from consequences of high blood sugar 
[3].  
Some of the references cited that the blood-glucose level is 
in the range of [4]: 
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𝐷𝑖𝑎𝑏𝑒𝑡𝑖𝑐
0, 4 𝑚𝑚𝑜𝑙/𝐿 𝐵𝐺𝐿 7 𝑚𝑚𝑜𝑙/𝐿
1,                    𝐵𝐺𝐿 7 𝑚𝑚𝑜𝑙/𝐿          (1) 
 
where, 0 = person without diabetic, 1 = person with possible 
diabetic 
For patients in a serious condition, continuous diabetes 
management or monitoring are essential. If the glucose level 
exceeds this level, the person is almost certainly suffering 
from diabetes. Continuous diabetes management may help in 
maintaining the sugar level in the acceptable range for the 
human body and it is essential to ensure that the patient does 
not develop the severe conditions induced by a high sugar 
level in the blood. Other health complications such as kidney 
failure, heart disease, and stroke may occur in the long term if 
it is not properly controlled [5].  
Estimated, 347 million people suffered from diabetes in 
2004, and around 3.4 million patients died from consequences 
of high blood sugar [13]. In many cases, the diabetes patients 
expressed their concerns towards the blood glucose 
examination and describing it as something painful with 
pinprick and pinch. The continuous monitoring towards the 
critical patients, involving pricking the fingers multiple times 
a day can be tiresome and painful. The process also difficult 
for the patients whose diagnose with dexterity limitation, 
aglophobia or with the anxiety problem. Frequent monitoring 
for diabetic patients, especially for those with a severe and 
serious condition, is a must as it is an incurable disease with a 
life-threatening metabolic disorder [6].   
II. METHODOLOGY 
This study flows consist of data acquisition both using the 
conventional glucose meter as the reference device and the 
NIR spectroscopy as the input data device. The input data 
were analyzed using the linear system identification model 
which is the ARMAX, to investigate the effectiveness of the 
linear model in predicting the glucose level in blood using the 
NIR wavelength. The dataset went through the pre-processing 
stage to enhance the feature of the input data set. 
III. DATA ACQUISITION 
The data collected from three groups which are the patients 
who were diagnosed with diabetic, the non-diabetic 
individuals and a control group without early diagnose and the 
process conducted under supervision of the personnel at 
Outpatient Department (OPD), Hospital Universiti Sains 
Malaysia (HUSM) Kubang Kerian, Kelantan, Malaysia. 
The human fingertips are among the best position to be 
measured besides the earlobe. This is because the skin of the 
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fingertips is much thinner and contains more blood vessels 
which are observable. The dataset contains 135 sets of data 
obtains from the three groups of subjects. The data taken from 
the subjects are varying in terms of gender, age, race or their 
medical condition (critical or not critical). The study on the 
subjects has to be performed in accordance to ethical 
principles of the Good Clinical Practice and the Declaration of 
Helsinki [7], [8]. Fig. 1 shows the illustrated setup of the NIR 
spectrometer during the data measurement. 
 
 
Fig. 1 The illustration of the NIR spectroscopy instrument 
IV. DATA PRE-PROCESSING 
For this research, the data pre-processing methods used are 
noise filtering, data sampling, interval correction and data 
distribution process. The Savitzky - Golay filter used to filter 
the wavelength, removing any unwanted information from the 
data set. The data sampling process extracted the wavelength 
with only the useful information to be fed as the input data set. 
Then, the data interval correction process is applied to selected 
peaks in the NIR spectrum. The data distribution process then 
implemented to divide the data into the training, testing and 
validation data set randomly. Fig. 2 shows the flow of the data 
pre-processing stage. 
V. SYSTEM IDENTIFICATION 
In this study, the linear model used is the ARMAX model. 
ARMAX model is defined as: 
 
𝐺 𝑧, 𝑝 , 𝐻 𝑧, 𝑝                        (2) 
 
where, 𝐴 𝑧 1 𝑎 𝑧 ⋯ 𝑎 𝑧 , 𝐵 𝑧 𝑏  𝑧 ⋯
𝑏 𝑧 𝐺 𝑝, 𝑧  and 𝐻 𝑝, 𝑧 are filters of finite order and 
functions of a parameter vector 𝑝, 
 
𝑝 𝑎 … . 𝑎   𝑏 … . 𝑏                 (3) 
 
The un-regularized and regularized ARMAX models are 
both implemented to determine the optimum testing result of 
the system. 
 
Noise filtering (raw data) 
 
 





Fig. 2 The flows of data pre-processing 
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VI. MODEL VALIDATION 
The Clarke Error Grid Analysis is widely used as a 
reference to quantify the clinical accuracy of patient estimates 
of the glucose levels in blood with the conventional invasive 
method [5], [9]-[11]. This method used to validate the linear 
system identification model which is implemented in this 
research. The data from output set and reference set are plotted 
to determine the region of distribution [12]. 
Region A: within 20% of the reference sensor (clinically 
accurate). 
Region B: outside of 20% but would not lead to an 
inappropriate treatment (clinically acceptable). 
Region C: leading to unnecessary treatment (overcorrection). 
Region D: indicating a potentially dangerous failure to detect 
hypoglycaemia or yperglycaemia (dangerous failure to detect). 
Region E: confuse treatment of hypoglycaemia for 
hyperglycaemia and vice versa (serious error). 
VII. RESULT 
The prediction result of the ARMAX model in Table I 
shows only 47.79% for un-regularized model and 50.11% for 
regularized model which are far from the satisfying results that 
should be obtained.  
 
TABLE I 




Training Testing Training Testing 
R R^2 % R R^2 % R R^2 % R R^2 % 
5 0.88 0.77 76.70 0.70 0.49 48.93 0.88 0.77 76.95 0.71 0.50 50.24 
7 0.88 0.77 77.14 0.71 0.50 49.98 0.87 0.76 76.46 0.71 0.51 50.52 
9 0.87 0.76 75.85 0.69 0.48 47.51 0.87 0.75 75.36 0.69 0.48 47.55 
11 0.88 0.77 76.90 0.70 0.48 48.50 0.86 0.74 74.49 0.69 0.48 48.22 
13 0.86 0.74 74.25 0.69 0.48 47.51 0.86 0.74 73.94 0.68 0.47 46.83 
15 0.86 0.75 74.75 0.68 0.47 46.62 0.86 0.74 73.94 0.69 0.47 47.32 
17 0.86 0.74 73.65 0.69 0.47 47.03 0.86 0.74 73.70 0.70 0.49 48.72 
19 0.86 0.74 74.06 0.69 0.47 47.42 0.86 0.74 73.99 0.70 0.49 48.65 
21 0.86 0.74 74.18 0.69 0.47 46.95 0.87 0.75 74.82 0.70 0.49 48.54 
23 0.86 0.74 73.96 0.67 0.45 45.36 0.87 0.75 74.89 0.69 0.47 46.95 
25 0.86 0.74 74.20 0.67 0.45 45.33 0.87 0.75 75.10 0.69 0.47 47.18 
27 0.87 0.76 75.78 0.68 0.47 46.64 0.87 0.76 76.02 0.70 0.49 48.69 
29 0.87 0.76 76.02 0.69 0.48 47.67 0.88 0.77 76.67 0.71 0.50 50.01 
31 0.88 0.77 76.70 0.69 0.48 48.09 0.88 0.77 77.11 0.71 0.50 49.86 
33 0.87 0.77 76.55 0.69 0.48 47.79 0.88 0.77 76.65 0.71 0.50 50.11 
 
The training and testing result with filter length 33 picked 
as the optimum value obtained which are from the modeling 
stage. The result from the Clarke Grid Error likewise is 
unsatisfying as shown in Fig. 3. From the figure, only 54.05% 
output data scattered in Region A for un-regularized model in 
(a), and 56.76% data scattered in Region A for regularized 






Fig. 3 (a) The scattering of the un-regularized testing data (b) The 
scattering of the regularized testing data
 
VIII. CONCLUSION 
The implementation of the linear system identification 
model is discussed in this paper, however resulting in the 
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ineffectiveness of the ARMAX model in predicting the output 
value of the NIR spectrum. The possible cause of the 
unsatisfying result is because of the influence from 
environmental and physiology factors during NIR 
measurement such as the human body and ambiance 
temperature or humidity, and also the patients’ skin color and 
textures. The implementation of the nonlinear models is 
proposed in future work to broaden the investigating 
parameter in order to improve the prediction result. 
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